Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Allogeneic bone marrow transplantation for leukemia

A Butturini1, R P Gale

  • 1University of Parma, Italy.

Current Opinion in Hematology
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential Habitability of Present-Day Martian Subsurface for Earth-Like Methanogens.

Astrobiology·2025
Same author

Origin, accumulation and fate of dissolved organic matter in an extreme hypersaline shallow lake.

Water research·2022
Same author

Dissolved organic matter in a tropical saline-alkaline lake of the East African Rift Valley.

Water research·2020
Same author

Can Long-Term Bone Marrow Culture Eliminate Leukemia Cells?

Leukemia & lymphoma·2016
Same author

Hydrological conditions control in situ DOM retention and release along a Mediterranean river.

Water research·2016
Same author

The effects of sediment depth and oxygen concentration on the use of organic matter: An experimental study using an infiltration sediment tank.

The Science of the total environment·2015

Allogeneic bone marrow transplants can cure certain leukemias through immune responses, not just intense pre-treatment. The exact mechanism of this graft-versus-leukemia effect remains unclear despite extensive research.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a curative option for several leukemia types, including acute lymphoblastic leukemia, acute myeloblastic leukemia, and chronic myelogenous leukemia.
  • Evidence suggests that the graft-versus-leukemia (GvL) effect, an immune-mediated antileukemia response, is the primary driver of cures, rather than solely relying on pretransplantation chemotherapy and radiation.
  • Despite over 20,000 allogeneic transplantations performed globally in leukemia patients over 25 years, the precise mechanism of the GvL effect is not yet understood.

Purpose of the Study:

  • To review the existing literature on allogeneic stem cell transplantation for leukemia.
  • To analyze the outcomes of allografts for leukemia based on single- and multicenter studies and the International Bone Marrow Transplant Registry.
  • To highlight the importance of immune-mediated effects in leukemia remission post-transplantation.

Related Experiment Videos

Main Methods:

  • Comprehensive review of single- and multicenter studies.
  • Analysis of data from the International Bone Marrow Transplant Registry.
  • Examination of outcomes in patients undergoing allogeneic transplantation for leukemia.

Main Results:

  • Allogeneic BMT has demonstrated curative potential in specific leukemia subtypes.
  • Immune-mediated graft-versus-leukemia effects are strongly implicated as the main mechanism for leukemia eradication.
  • The precise immunological mechanisms underlying the GvL effect require further elucidation.

Conclusions:

  • Allogeneic transplantation offers a cure for some leukemia patients, primarily through immune mechanisms.
  • Understanding the graft-versus-leukemia effect is crucial for optimizing leukemia treatment strategies.
  • Further research is needed to fully elucidate the GvL mechanism and enhance its therapeutic application.